Steve Horvath
Steve Horvath is a biostatistician and geneticist known for his work in epigenetics and aging research. He is a professor at the University of California, Los Angeles (UCLA) in the Department of Human Genetics and the Department of Biostatistics.
Early Life and Education[edit | edit source]
Steve Horvath was born in Germany and later moved to the United States. He earned his Ph.D. in mathematics from the University of North Carolina at Chapel Hill and completed his postdoctoral training in biostatistics at the Harvard School of Public Health.
Career[edit | edit source]
Horvath's research primarily focuses on the development of biomarkers for aging and age-related diseases. He is best known for creating the epigenetic clock, a tool that uses DNA methylation levels to estimate the biological age of cells, tissues, and organs. This groundbreaking work has significant implications for understanding the aging process and developing interventions to promote healthy aging.
Epigenetic Clock[edit | edit source]
The epigenetic clock is a highly accurate biomarker of aging, which Horvath developed by analyzing DNA methylation data. This clock can predict the biological age of various tissues and cell types, providing insights into the aging process and potential age-related diseases. The epigenetic clock has been widely used in gerontology and biomedical research to study the effects of aging and to evaluate the effectiveness of anti-aging therapies.
Awards and Recognition[edit | edit source]
Steve Horvath has received numerous awards for his contributions to the field of aging research, including the Mildred S. Dresselhaus Prize and the EUREKA Award from the National Institutes of Health (NIH). His work has been published in leading scientific journals and has garnered significant attention from the scientific community and the media.
Personal Life[edit | edit source]
Horvath resides in Los Angeles, California, where he continues his research and teaching at UCLA. He is actively involved in various scientific organizations and frequently collaborates with researchers worldwide.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
